IRIS
FEDERICO, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.182
NA - Nord America 7.571
AS - Asia 1.497
SA - Sud America 69
OC - Oceania 19
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.359
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.512
IE - Irlanda 2.402
IT - Italia 1.546
UA - Ucraina 1.267
GB - Regno Unito 962
SG - Singapore 577
DE - Germania 445
CN - Cina 428
FR - Francia 394
SE - Svezia 373
FI - Finlandia 337
GR - Grecia 256
TR - Turchia 255
KR - Corea 67
VN - Vietnam 55
BR - Brasile 47
PL - Polonia 42
IN - India 37
NL - Olanda 35
BE - Belgio 34
RU - Federazione Russa 26
CA - Canada 25
MX - Messico 25
AU - Australia 18
IR - Iran 16
ES - Italia 15
JP - Giappone 15
PK - Pakistan 14
AT - Austria 13
CZ - Repubblica Ceca 10
AR - Argentina 9
HK - Hong Kong 9
EG - Egitto 8
EC - Ecuador 6
MK - Macedonia 6
ID - Indonesia 5
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
RO - Romania 4
ET - Etiopia 3
EU - Europa 3
NO - Norvegia 3
PE - Perù 3
TW - Taiwan 3
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
LT - Lituania 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
TH - Thailandia 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BF - Burkina Faso 1
BG - Bulgaria 1
CO - Colombia 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 17.359
Salva come PNG Salva come JPEG
Città #
Dublin 2.398
Jacksonville 1.918
Chandler 1.229
Santa Clara 437
Princeton 378
Singapore 333
Roxbury 311
Ann Arbor 225
Cambridge 220
Boardman 205
Naples 187
Medford 169
Wilmington 159
Beijing 147
Woodbridge 137
New York 130
Caserta 89
Des Moines 87
San Mateo 78
Houston 77
Mountain View 66
Nanjing 64
Bremen 61
Ashburn 54
Dong Ket 54
Rome 50
Seoul 47
Napoli 40
Düsseldorf 39
Munich 34
Kraków 33
Brussels 30
Norwalk 28
Milan 27
Shenyang 27
Jinan 26
Potenza 25
Auburn Hills 21
Los Angeles 20
Aversa 19
Boydton 19
Helsinki 19
Amsterdam 18
Paris 18
Bologna 14
Nanchang 14
Sennori 14
Bari 13
Palermo 12
Redwood City 11
Salerno 11
Changsha 10
Jinju 10
Kunming 10
Venice 10
Vienna 10
Catania 9
Fairfield 9
Lappeenranta 9
Mexico 9
Shanghai 9
Zhengzhou 9
Angers 8
Atella 8
Brno 8
Cattolica 8
Florence 8
Groningen 8
Hanover 8
Ottawa 8
Tianjin 8
Haikou 7
Hebei 7
Hyderabad 7
Lahore 7
Lanzhou 7
Pescara 7
Portici 7
Porto Alegre 7
Seregno 7
Borgomanero 6
London 6
Madrid 6
Orange 6
St Petersburg 6
São Paulo 6
Torino 6
Bacoli 5
Bovisio 5
Brighton 5
Daejeon 5
Hangzhou 5
Hong Kong 5
Jiaxing 5
Lissone 5
Moscow 5
Mumbai 5
Nola 5
Quito 5
San Mango 5
Totale 10.188
Salva come PNG Salva come JPEG
Nome #
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 193
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 109
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 107
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 105
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 104
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 103
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 103
Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: the interim analysis of the ANSWER study 101
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 99
Intrafamilial spread of Helicobacter pylori infection 94
Comparsa di pancreatite acuta ed epatite autoimmune in corso di trattamento con IFN: descrizione di un caso clinico. 88
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 87
Angiografia perfusionale con mdc di 2a generazione nella valutazione della efficacia necrotica delle terapie ablative percutanee (PAT): studio prospettico vs TC spirale. 87
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 87
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 76
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 76
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 74
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 74
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 73
Chronic inflammation and oxidative stress in human carcinogenesis 73
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 73
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 73
Alteration of haemostasis in non-metastatic gastric cancer 72
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 72
Obesità androide postmenopausale: ruolo del DHEA-S, didrotestosterone libero ed SHBG. 71
null 70
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 70
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 70
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 69
A case of hepatotoxicity caused by green tea 69
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 69
The role of a probiotic (FLORTEC, Bracco S.p.A., Italy) on the plasma levels and peripheral blood mononuclear cell expression of cytokines in patients with ulcerative colitis: a pilot study. 69
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 67
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 67
Crohn’s disease and skin 66
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases 66
Aggregazione piastrinica in pazienti con epatite cronica da HCV: studi in vitro. 65
Rapporti fra alimentazione e stato nutrizionale in pazienti con cirrosi epatica. 65
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 65
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 64
Il “pianeta” fegato grasso nella pratica clinica. Dalla Diagnosi alla terapia 64
The Role of Stress in Inflammatory Bowel Diseases 64
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 63
Sequential therapy for eradication of Helicobacter pilori infection 63
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 63
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 63
Trace elements and chronic liver diseases 62
Valutazione dell’effetto di silibina+fosfatidilcolina+vitamina E vs placebo sul danno epatico in pazienti con NAFLD (nonalcoholic fatty liver disease): risultati di un trial clinico europeo randomizzato in doppio cieco. 62
Cause di malnutrizione nel paziente neoplastico 61
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 61
Effetti di un nuovo composto farmaceutico (Sillibina, fosfolipidi e vitamina E) sulla protezione del danno prodotto dall’alcol su cellule di adenocarcinoma gastrico MKN-28. 61
Tiroidite autoimmune in corso di trattamento con IFN in pazienti affetti da epatite cronica HCV-correlata. 61
Efficacia di terapia quadruplice concomitante di cinque giorni per l’eradicazione dell’infezione dell’H. pylori in pazienti naive al trattamento. 61
Sindrome di Zollinger-Ellison associata a malattia celiaca: descrizione di un caso clinico. 61
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 61
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 61
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 60
Le abitudini alimentari influenzano i livelli plasmatici di aminoacidi e oligoelementi nel paziente cirrotico? 60
Chronic treatment with sylibin significantly improves insulin-resistance in patients with nonalcoholic fatty liver disease. 60
AISF position paper on liver disease and pregnancy 60
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial 59
La steatoepatite non alcolica (NAFLD): studio multicentrico italiano. 59
Oligoelementi ed epatopatie: rapporti con la gravità di malattia e lo stato nutrizionale. 59
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 59
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 58
Obesità viscerale ed insulino-resistenza in corso di NASH. 57
L’utilizzo di farmaci anti-TNF nella Malattia di Crohn 57
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 57
Alcoholic hepatitis: Pathogenesis, diagnosis and treatment 57
Activated protein C resistance in nonmetastatic gastric cancer patients. 56
Treatment of chronic hepatic encephalopathy with rifaximin. In: Encefalopatia epatica 56
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 56
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 56
Hashimoto’s thyroiditis and entero-chromaffin-like cell hyperplasia: early detection and somatostatin analogue treatment. 55
Humerus metastasis from cholangiocarcinoma: a case report 55
Effetto del trattamento cronico con sillibina sull’insulino-resistenza e sui marcatori plasmatici di fibrosi epatica in pazienti con malattia cronica di fegato. 55
Interazione tra alcol e cofattori sul rischio di cirrosi epatica. 55
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 55
Una spia sulla tavola dei nostri ragazzi 55
Fibrinogeno ed acido urico quali fattori di rischio cardiovascolare in pazienti obesi. 54
Alcoholic liver disease and hepatitis C chronic infection 54
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 54
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 53
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 53
Alcohol consumption among young people in Italy: a “Facebook survey” 53
Effetti metabolici della silibina: studi in vitro e in vivo. 53
Permeabilità intestinale e malattie epatiche. 53
Differente risposta allo stress ossidativo fra maschi e femmine in pazienti affetti da epatite cronica da HCV. 53
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 52
Alcohol intake and interferon therapy in patients with HCV-related chronic hepatitis. 52
Effect of Silybin in patients with chronic hepatitis: preliminary results of a multicentre randomized controlled trial vs placebo. 52
Emostasi e cancro dello stomaco non metastatico. 52
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 52
'' Non alcoholic fatty liver disease and eNOS dysfunction in humans '' 52
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 52
Gut microbiota and the liver 52
Gut microbiota, obesity and metabolic disorders 52
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 52
Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures 52
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 52
Totale 6.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.242 0 0 0 0 335 85 397 111 113 89 87 25
2020/20212.835 225 20 321 205 374 32 392 316 39 388 364 159
2021/20222.238 95 20 27 67 784 32 54 61 88 64 204 742
2022/20234.584 448 120 49 373 454 373 17 304 2.228 44 81 93
2023/20242.095 155 69 78 151 686 169 55 58 35 68 205 366
2024/20251.092 52 78 147 233 582 0 0 0 0 0 0 0
Totale 17.849